Invivyd, Inc. expected to post a loss of 11 cents a share - Earnings Preview
Invivyd, Inc. expected to post a loss of 11 cents a share - Earnings Preview
Invivyd, Inc. IVVD.OQ IVVD.O is expected to show a rise in quarterly revenue when it reports results on August 12 (estimated) for the period ending June 30 2026
The New Haven Connecticut-based company is expected to report a 22.2% increase in revenue to $14.4 million from $11.79 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.
LSEG's mean analyst estimate for Invivyd, Inc. is for a loss of 11 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Invivyd, Inc. is $10.00, about 1,251.4% above its last closing price of $0.74
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Mar. 31 2026 | -0.08 | -0.07 | -0.13 | Missed | -77.3 |
Dec. 31 2026 | -0.08 | -0.09 | -0.04 | Beat | 54.3 |
Sep. 30 2025 | -0.08 | -0.08 | -0.06 | Beat | 25 |
Jun. 30 2025 | -0.04 | -0.02 | -0.12 | Missed | -414.4 |
Mar. 31 2025 | -0.02 | -0.03 | -0.14 | Missed | -366.7 |
Dec. 31 2024 | -0.22 | -0.20 | -0.20 | Met | 0 |
Sep. 30 2024 | -0.35 | -0.34 | -0.51 | Missed | -51.1 |
Jun. 30 2024 | -0.38 | -0.37 | -0.40 | Missed | -7.1 |
This summary was machine generated August 10 at 11:37 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Recent news on Invivyd
See all newsBrief: Invivyd Announces Positive Topline Results From Liberty Phase 3 Study Demonstrating Vyd2311 Safety And Tolerability Superior To Mrna-Based Covid-19 Vaccine Announces Regulatory Submission Plans For Vyd2311
Invivyd, Inc. reports results for the quarter ended June 30 - Earnings Summary
Invivyd Q2 loss per share comes wider than expected on higher costs
Brief: Invivyd Q2 EPS USD -0.14
Invivyd, Inc. expected to post a loss of 11 cents a share - Earnings Preview